These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

325 related items for PubMed ID: 23328511

  • 41. Twelve-month results of the rapid renal sympathetic denervation for resistant hypertension using the OneShotTM ablation system (RAPID) study.
    Verheye S, Ormiston J, Bergmann MW, Sievert H, Schwindt A, Werner N, Vogel B, Colombo A.
    EuroIntervention; 2015 Feb; 10(10):1221-9. PubMed ID: 25452198
    [Abstract] [Full Text] [Related]

  • 42. Renal denervation preserves renal function in patients with chronic kidney disease and resistant hypertension.
    Ott C, Mahfoud F, Schmid A, Toennes SW, Ewen S, Ditting T, Veelken R, Ukena C, Uder M, Böhm M, Schmieder RE.
    J Hypertens; 2015 Jun; 33(6):1261-6. PubMed ID: 25923731
    [Abstract] [Full Text] [Related]

  • 43. Effect of renal nerve denervation for resistant hypertension in Thai patients: a report of the first cases series in Thailand.
    Wongpraparut N, Tresukosol D, Roubsantisuk W, Buranakitjaroen P, Chotivoraniyakul C, Pongakasira R.
    J Med Assoc Thai; 2014 Mar; 97 Suppl 3():S155-61. PubMed ID: 24772593
    [Abstract] [Full Text] [Related]

  • 44. Renal nerve ablation reduces augmentation index in patients with resistant hypertension.
    Hering D, Lambert EA, Marusic P, Ika-Sari C, Walton AS, Krum H, Sobotka PA, Mahfoud F, Böhm M, Lambert GW, Esler MD, Schlaich MP.
    J Hypertens; 2013 Sep; 31(9):1893-900. PubMed ID: 23697964
    [Abstract] [Full Text] [Related]

  • 45. Renal denervation therapy for the treatment of resistant hypertension: a position statement by the Canadian Hypertension Education Program.
    Khan NA, Herman RJ, Quinn RR, Rabkin SW, Ravani P, Tobe SW, Feldman RD, Wijeysundera HC, Padwal RS, Canadian Hypertension Education Program.
    Can J Cardiol; 2014 Jan; 30(1):16-21. PubMed ID: 24269056
    [Abstract] [Full Text] [Related]

  • 46. Denervation of nerve terminals in renal arteries: one-year follow-up of interventional treatment of arterial hypertension.
    Bartuś K, Sadowski J, Kapelak B, Litwinowicz R, Zajdel W, Godlewski J, Bartuś M, Zmudka K, Chrapusta A, Konstanty-Kalandyk J, Węgrzyn P, Sobotka PA.
    Kardiol Pol; 2014 Jan; 72(5):425-31. PubMed ID: 24408071
    [Abstract] [Full Text] [Related]

  • 47. Effect of renal denervation on left ventricular mass and function in patients with resistant hypertension: data from a multi-centre cardiovascular magnetic resonance imaging trial.
    Mahfoud F, Urban D, Teller D, Linz D, Stawowy P, Hassel JH, Fries P, Dreysse S, Wellnhofer E, Schneider G, Buecker A, Schneeweis C, Doltra A, Schlaich MP, Esler MD, Fleck E, Böhm M, Kelle S.
    Eur Heart J; 2014 Sep 01; 35(33):2224-31b. PubMed ID: 24603307
    [Abstract] [Full Text] [Related]

  • 48. Renal artery anatomy affects the blood pressure response to renal denervation in patients with resistant hypertension.
    Hering D, Marusic P, Walton AS, Duval J, Lee R, Sata Y, Krum H, Lambert E, Peter K, Head G, Lambert G, Esler MD, Schlaich MP.
    Int J Cardiol; 2016 Jan 01; 202():388-93. PubMed ID: 26432488
    [Abstract] [Full Text] [Related]

  • 49.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 50.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 51.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 52.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 53. Percutaneous renal denervation in patients with treatment-resistant hypertension: final 3-year report of the Symplicity HTN-1 study.
    Krum H, Schlaich MP, Sobotka PA, Böhm M, Mahfoud F, Rocha-Singh K, Katholi R, Esler MD.
    Lancet; 2014 Feb 15; 383(9917):622-9. PubMed ID: 24210779
    [Abstract] [Full Text] [Related]

  • 54.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 55. The effect of two different renal denervation strategies on blood pressure in resistant hypertension: Comparison of full-length versus proximal renal artery ablation.
    Chen W, Ling Z, Du H, Song W, Xu Y, Liu Z, Su L, Xiao P, Yuan Y, Lu J, Zhang J, Li Z, Shao J, Zhong B, Zhou B, Woo K, Yin Y.
    Catheter Cardiovasc Interv; 2016 Nov 15; 88(5):786-795. PubMed ID: 27219520
    [Abstract] [Full Text] [Related]

  • 56. Impact of Medication Adherence on the Effect of Renal Denervation: The SYMPATHY Trial.
    de Jager RL, de Beus E, Beeftink MM, Sanders MF, Vonken EJ, Voskuil M, van Maarseveen EM, Bots ML, Blankestijn PJ, SYMPATHY Investigators.
    Hypertension; 2017 Apr 15; 69(4):678-684. PubMed ID: 28264922
    [Abstract] [Full Text] [Related]

  • 57.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 58.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 59. Effects of renal denervation on ambulatory blood pressure measurements in patients with resistant arterial hypertension.
    Lambert T, Blessberger H, Gammer V, Nahler A, Grund M, Kerschner K, Buchmayr G, Saleh K, Kammler J, Steinwender C.
    Clin Cardiol; 2014 May 15; 37(5):307-11. PubMed ID: 24700288
    [Abstract] [Full Text] [Related]

  • 60.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 17.